Dashboard
Manage Tickers

BCRXBIOCRYST PHARMACEUTICALS INC

Nasdaq biocryst.com


$ 5.29 $ -0.10 (-1.86 %)    

Tuesday, 07-May-2024 15:34:01 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.35 $ 0.83 (0.19 %)
DIA $ 388.83 $ -0.35 (-0.09 %)
SPY $ 517.24 $ -0.34 (-0.07 %)
TLT $ 90.68 $ -0.17 (-0.19 %)
GLD $ 214.01 $ -0.51 (-0.24 %)
$ 5.27
$ 5.39
$ 5.30 x 100
$ 5.31 x 200
$ 5.26 - $ 5.64
$ 4.03 - $ 8.96
8,895,832
na
1.01B
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 02-27-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-13-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-14-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 03-12-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 02-27-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-08-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 02-26-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 03-02-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-09-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-maintains-market-outperform-on-biocryst-pharma-raises-price-target-to-15
JMP Securities Maintains Market Outperform...
05/07/2024 15:29:42

JMP Securities analyst Jonathan Wolleben maintains BioCryst Pharma (NASDAQ:BCRX) with a Market Outperform and raises the pri...

hc-wainwright--co-reiterates-buy-on-biocryst-pharma-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
05/07/2024 10:16:41

HC Wainwright & Co. analyst Andrew Fein reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $30 price target.

needham-reiterates-buy-on-biocryst-pharma-maintains-12-price-target
Needham Reiterates Buy on BioCryst Pharma,...
05/07/2024 09:33:05

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target.

biocryst-pharmaceuticals-fantastic-q1-earnings-rides-on-outstanding-orladeyo-performance
BioCryst Pharmaceuticals 'Fantastic' Q1 Ea...
05/06/2024 18:59:35

BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by...

why-perficient-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-in-mondays-mid-day-session
Why Perficient Shares Are Trading Higher B...
05/06/2024 16:32:34

biocryst-forecasts-2024-orladeyo-revenue-of-390m-400m-the-top-end-of-its-prior-guidance-range-of-380m-400m
Biocryst Forecasts 2024 Orladeyo Revenue O...
05/06/2024 11:05:22

biocryst-pharma-q1-2024-adj-eps-017-beats-021-estimate-sales-92761m-beat-85605m-estimate
BioCryst Pharma Q1 2024 Adj EPS $(0.17) Be...
05/06/2024 11:03:10

biocryst-pharmaceuticals-announced-that-the-brazilian-health-regulatory-agency-has-granted-approval-for-oral-once-daily-orladeyo-berotralstat-for-the-prophylaxis-of-hereditary-angioedema-hae-attacks-in-adults-and-pediatric-patients-12-years
BioCryst Pharmaceuticals Announced That Th...
04/17/2024 08:36:06

needham-reiterates-buy-on-biocryst-pharma-maintains-12-price-target
Needham Reiterates Buy on BioCryst Pharma,...
04/10/2024 11:10:05

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target.

whats-going-on-with-biocryst-stock-after-earnings
What's Going On With BioCryst Stock After ...
02/26/2024 18:30:11

BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
02/26/2024 17:35:26

li-auto-posts-q4-earnings-joins-teva-pharmaceutical-and-other-big-stocks-moving-higher-in-mondays-pre-market-session
Li Auto Posts Q4 Earnings, Joins Teva Phar...
02/26/2024 12:03:47

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

biocryst-forecasts-fiscal-year-2024-orladeyo-net-revenue-of-380m-400m-the-company-expects-operating-profit-in-2024-approaching-positive-eps-and-positive-cash-flow-in-2h-2025
BioCryst Forecasts Fiscal Year 2024 Orlade...
02/26/2024 12:02:59

biocryst-pharma-q4-adjusted-eps-028-misses-024-estimate-sales-9340m-beat-9001m-estimate
BioCryst Pharma Q4 Adjusted EPS $(0.28) Mi...
02/26/2024 12:01:37

BioCryst Pharma (NASDAQ:BCRX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0...

earnings-scheduled-for-february-26-2024
Earnings Scheduled For February 26, 2024
02/26/2024 09:47:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

a-preview-of-biocryst-pharmas-earnings
A Preview Of BioCryst Pharma's Earnings
02/23/2024 19:01:35

biocryst-pharmaceuticals-says-new-analyses-of-real-world-use-of-oral-once-daily-orladeyo-berotralstat-showed-patients-who-initiated-orladeyo-experienced-rapid-substantial-and-sustained-reductions-in-attack-rates-through-18-months-of-treatment
BioCryst Pharmaceuticals Says New Analyses...
02/23/2024 12:05:21

reported-monday-biocryst-launches-orladeyo-in-italy-for-hereditary-angioedema-prevention
Reported Monday, BioCryst Launches ORLADEY...
02/20/2024 08:48:57

 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco ...

why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session
Why RxSight Shares Are Trading Higher By 2...
01/08/2024 18:36:30

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

whats-going-on-with-biocryst-pharmaceuticals-stock
What's Going On With BioCryst Pharmaceutic...
01/08/2024 16:41:17

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION